UC Board of Regents Gives Approval for New Clinical and Translational Research Institute Building on UC San Diego’s La Jolla Campus

 

November 18, 2010  |  

The University of California Board of Regents on Tuesday approved the budget for capital improvements and external financing for the Clinical and Translational Research Institute (CTRI) building, to be constructed on the medical campus of UC San Diego in La Jolla.  The CTRI building will be in close proximity to Thornton Hospital, Moores Cancer Center, the soon-to-open Sulpizio Cardiovascular Center and the recently announced Jacobs Medical Center.

“The CTRI building will create a unique multidisciplinary environment that brings together laboratory scientists and clinical investigators to understand disease, develop new methods of treatment and translate clinical research results into clinical practice,” said Gary S. Firestein, MD, professor of medicine, dean and associate vice chancellor of Translational Medicine and director of the Clinical and Translational Research Institute at UCSD School of Medicine.

The new building, currently slated for completion in late 2016, will comprise 311,000 gsf and 189,000 asf (assignable square feet) including  wet and dry research space, and clinical research space to support investigators in the School of Medicine.

The projected cost of the project is $269 million, which will be primarily paid for with external funding sources rather than state dollars, according to UC San Diego administrators.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu




Media Contact

Share This Article


Related News

12/11/2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before ...
12/11/2017
In remote Italian villages nestled between the Mediterranean Sea and mountains lives a group of several hundred citizens over the age of 90. Researchers at the University of Rome La Sapienza and Unive ...
12/11/2017
Researchers at University of California San Diego School of Medicine have found a genetic signature for delay discounting — the tendency to undervalue future rewards — that overlaps with attention-def ...
12/5/2017
Using a database of multiple myeloma patient samples and information, researchers at University of California San Diego School of Medicine found that high ADAR1 levels correlate with reduced survival ...



Follow Us